Age at initiation of treatment and the type of biologic therapy prescribed effect the rate of drug survival among patients with psoriasis.

A much touted emerging treatment, red light therapy, lives up to the hype for a lot of health claims, but certainly not ...

Discover a recent study that has provided valuable insights into the experiences of Latine patients living with moderate to ...

Many people with ongoing medical conditions experience more symptoms during the winter. Here's why, and what you can do.

Arcutis Biotherapeutics has a lofty goal for 2025 — and it could help Arcutis stock continue a massive run that helped shares ...

Wet dandruff—or dandruff associated with an oily scalp—happens when extra sebum (oil) production on the scalp combines with ...

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.

Vitiligo is a condition that affects millions worldwide, yet it remains widely misunderstood. Characterised by white patches on the skin, it is an autoimmune di ...

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its price target lifted by analysts at JPMorgan Chase & Co. from $51.00 to $53.00 in a research note issued to investors on ...

Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the stock, Marketbeat.com ...

The News took your common skincare concerns to the Yukon skincare experts for solutions that don't involve a trip down south ...